Relay Therapeutics

Developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion

Company website

Ticker

RLAY.NASDAQ

Market

Foundation year

2016

Potential

192%

Close date

8/9/2020

IPO date

7/15/2020

Placement price

$20

Open price

$35.09

Profitability

102.5%

About

Total Funding

$870M

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.The company's platform detects and characterizes interactions that occur anywhere on a protein and combines computational methods with experimental approaches across the fields of structural biology, biophysics and chemistry, enabling pharmaceutical companies to solve and design therapies against complex diseases like cancer and others.

Number of employees

100 - 250

Headquarters

Cambridge, Massachusetts, United States